Luying Pan

2.7k total citations · 1 hit paper
36 papers, 2.0k citations indexed

About

Luying Pan is a scholar working on Immunology, Physiology and Hematology. According to data from OpenAlex, Luying Pan has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Physiology and 11 papers in Hematology. Recurrent topics in Luying Pan's work include Lysosomal Storage Disorders Research (12 papers), Hematopoietic Stem Cell Transplantation (10 papers) and T-cell and B-cell Immunology (10 papers). Luying Pan is often cited by papers focused on Lysosomal Storage Disorders Research (12 papers), Hematopoietic Stem Cell Transplantation (10 papers) and T-cell and B-cell Immunology (10 papers). Luying Pan collaborates with scholars based in United States, United Kingdom and China. Luying Pan's co-authors include James L.M. Ferrara, Kenneth R. Cooke, Geoffrey R. Hill, Yani S. Brinson, James M. Crawford, Takanori Teshima, Werner Krenger, Armin Gerbitz, C. Eduardo Corrales and Albert S.B. Edge and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Luying Pan

35 papers receiving 2.0k citations

Hit Papers

Total Body Irradiation and Acute Graft-Versus-Host Diseas... 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luying Pan United States 17 1.1k 1.1k 321 302 251 36 2.0k
Daniel Ryan United States 16 424 0.4× 564 0.5× 79 0.2× 255 0.8× 125 0.5× 43 1.4k
Alexandra Schnell United States 12 253 0.2× 713 0.7× 136 0.4× 329 1.1× 208 0.8× 16 1.2k
Toshio Yabe Japan 23 388 0.4× 885 0.8× 44 0.1× 147 0.5× 104 0.4× 53 1.4k
Patricia Hermand France 25 740 0.7× 408 0.4× 647 2.0× 313 1.0× 208 0.8× 37 1.5k
Laura G. Schuettpelz United States 16 890 0.8× 986 0.9× 145 0.5× 609 2.0× 358 1.4× 34 2.2k
Jenny Chia Australia 14 285 0.3× 284 0.3× 109 0.3× 257 0.9× 187 0.7× 21 1.2k
Daniel Pietryga United States 14 759 0.7× 518 0.5× 420 1.3× 817 2.7× 305 1.2× 22 2.1k
Julie Wheway Australia 14 109 0.1× 1.4k 1.3× 573 1.8× 352 1.2× 240 1.0× 15 2.5k
Luciana Rigoli Italy 23 122 0.1× 362 0.3× 196 0.6× 491 1.6× 155 0.6× 84 1.5k
Jacqueline Shaw United Kingdom 20 407 0.4× 593 0.6× 108 0.3× 416 1.4× 89 0.4× 26 1.4k

Countries citing papers authored by Luying Pan

Since Specialization
Citations

This map shows the geographic impact of Luying Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luying Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luying Pan more than expected).

Fields of papers citing papers by Luying Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luying Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luying Pan. The network helps show where Luying Pan may publish in the future.

Co-authorship network of co-authors of Luying Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Luying Pan. A scholar is included among the top collaborators of Luying Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luying Pan. Luying Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mora, Johanna, et al.. (2026). Anti-drug Antibody Validation Testing and Reporting Harmonization Addendum. The AAPS Journal. 28(1). 47–47.
2.
Argueta, Christian, Oeystein Roed Brekk, Scott R. McDonnell, et al.. (2025). A link between baseline neurofilament light chain and primary substrate accumulation in cerebrospinal fluid, and clinical outcomes in patients with MPS II from a phase 2/3 clinical trial and extension study of intrathecal idursulfase. Molecular Genetics and Metabolism. 144(3). 109055–109055. 1 indexed citations
3.
Peng, Yu‐Xin, Luying Pan, Kang Ouyang, et al.. (2024). Immunogenicity analysis based on VP1 and VP2 proteins of bovine enterovirus. Virology. 600. 110260–110260. 2 indexed citations
4.
Pabinger, Ingrid, Miguel A. Escobar, Barbara A. Konkle, et al.. (2024). Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia. Gene Therapy. 31(5-6). 273–284. 9 indexed citations
5.
Pan, Luying, Michael Y. Chen, Jing Ping Sun, et al.. (2023). Prediction of Fuhrman grade of renal clear cell carcinoma by multimodal MRI radiomics: a retrospective study. Clinical Radiology. 79(2). e273–e281. 4 indexed citations
6.
Chen, Mu, Zhiling Zhang, Carolina Fischinger Moura de Souza, et al.. (2018). A Novel LC–MS/MS Assay to Quantify Dermatan Sulfate in Cerebrospinal Fluid as a Biomarker for Mucopolysaccharidosis II. Bioanalysis. 10(11). 825–838. 12 indexed citations
7.
Pan, Luying, et al.. (2017). A Rapid Two-Step Iduronate-2-Sulfatatse Enzymatic Activity Assay for MPSII Pharmacokinetic Assessment. JIMD Reports. 38. 89–95. 5 indexed citations
8.
Pan, Luying, et al.. (2017). A Comparison Study of Bioanalytical Methods for Characterization of Anti-Idursulfase Antibodies. Bioanalysis. 9(16). 1237–1246. 1 indexed citations
9.
Jones, Simon, Catherine Breen, Stewart Rust, et al.. (2016). A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA. Molecular Genetics and Metabolism. 118(3). 198–205. 83 indexed citations
10.
Hendriksz, Christian J., Joseph Muenzer, Adeline Vanderver, et al.. (2015). Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment. SHILAP Revista de lepidopterología. 5. 103–106. 27 indexed citations
11.
Muenzer, Joseph, Christian J. Hendriksz, Zheng Fan, et al.. (2015). A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II. Genetics in Medicine. 18(1). 73–81. 140 indexed citations
12.
Muenzer, Joseph, Christian J. Hendriksz, Zheng Fan, et al.. (2015). Long-term biomarker and cognitive follow-up of children with Hunter syndrome receiving intrathecal enzyme replacement therapy. Molecular Genetics and Metabolism. 114(2). S83–S83. 1 indexed citations
14.
Corrales, C. Eduardo, Luying Pan, Huawei Li, et al.. (2006). Engraftment and differentiation of embryonic stem cell–derived neural progenitor cells in the cochlear nerve trunk: Growth of processes into the organ of corti. Journal of Neurobiology. 66(13). 1489–1500. 152 indexed citations
15.
Reddy, Vijay, Geoffrey R. Hill, Luying Pan, et al.. (2000). G-CSF MODULATES CYTOKINE PROFILE OF DENDRITIC CELLS AND DECREASES ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH EFFECTS ON THE DONOR RATHER THAN THE RECIPIENT. Transplantation. 69(4). 691–693. 73 indexed citations
16.
Hill, Geoffrey R., Takanori Teshima, Armin Gerbitz, et al.. (1999). Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia. Journal of Clinical Investigation. 104(4). 459–467. 201 indexed citations
17.
Teshima, Takanori, Geoffrey R. Hill, Luying Pan, et al.. (1999). IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. Journal of Clinical Investigation. 104(3). 317–325. 147 indexed citations
19.
Krenger, Werner, Kenneth R. Cooke, James M. Crawford, et al.. (1996). TRANSPLANTATION OF POLARIZED TYPE 2 DONOR T CELLS REDUCES MORTALITY CAUSED BY EXPERIMENTAL GRAFT-VERSUS-HOST DISEASE1. Transplantation. 62(9). 1278–1285. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026